ABSTRACT
Cerebral aneurysms are a serious clinical challenge, with ∼half resulting in death or disability. Treatment via endovascular coiling significantly reduces the chances of rupture, but the technique has failure rates between 25-40%. This presents a pressing need to develop a method for determining optimal coil deployment strategies. Quantification of aneurysm hemodynamics through computational fluid dynamics (CFD) has the potential to significantly improve the understanding of the mechanics of aneurysm coiling and improve treatment outcomes, but accurately representing the coil mass in CFD simulations remains a challenge. We have used the Finite Element Method (FEM) for simulating patient-specific coil deployment based on mechanical properties and coil geometries provided by the device manufacturer for n=4 ICA aneurysms for which 3D printed in vitro models were also generated, coiled, and scanned using ultra-high resolution synchrotron micro-CT. The physical and virtual coil geometries were voxelized onto a binary structured grid and porosity maps were generated for geometric comparison. The average binary accuracy score is 0.836 and the average error in porosity map is 6.3%. We then conduct patient-specific CFD simulations of the aneurysm hemodynamics using virtual coils geometries, micro-CT generated oil geometries, and using the porous medium method to represent the coil mass. Hemodynamic parameters of interest including were calculated for each of the CFD simulations. The average error across hemodynamic parameters of interest is ∼19%, a 58% reduction from the average error of the porous media simulations, demonstrating a marked improvement in the accuracy of CFD simulations using FEM generated coil geometries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by NIH/NINDS 1R01NS105692; an unrestricted educational grant from Stryker, which had no influence on the study design or results; and the generous support of the Catchot family.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The use of patient data for this work was approved by the Institutional Review Board at the university of Washington.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author
